CareDx, Inc., headquartered in Brisbane, California, is a leading precision medicine company focused on the discovery, development and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. The Company’s commercially available testing services consist of AlloSure® Kidney, which is a donor-derived cell-free DNA (“dd-cfDNA”) solution for kidney transplant patients, and AlloMap® Heart, which is a gene expression solution for heart transplant patients. The Company also offers high-quality products that increase the chance of successful transplants by facilitating a better match between a donor and a recipient of stem cells and organs.
CareDx trades on the NASDAQ exchange under the ticker symbol “CDNA”.
CareDx completed its initial public offering on July 16, 2014.
The Company’s headquarters are located in Brisbane, California. Principal offices are located at 8000 Marina Boulevard, Brisbane CA 94005. The telephone number is (415) 287-2300.
The biographies of CareDx’s directors are available in the “Board of Directors” section of our Investor Relations website.
The biographies of CareDx’s management team are available in the “Leadership” section of our Investor Relations website
CareDx’s fiscal year ends December 31st.
CareDx’s independent auditor is Deloitte & Touche LLP, with its address at 225 W. Santa Clara Street, Suite 600, San Jose, CA 95113. The phone number is (408) 704-4000.
CareDx’s outside legal counsel is Paul Hastings.
No, CareDx does not pay a dividend at this time.
No, CareDx does not offer a direct stock purchase program.
CareDx’s quarterly and annual reports and other SEC filings are available by selecting the “Financial Information” section of our “Investors” page on our website or through SEC’s website.
The next annual stockholders meeting for 2020 will be on June 17.
CareDx uses Computershare as its transfer agent and contact information is provided below. Computershare P.O. Box 30170 College Station, TX 77842-3170 Toll Free: 1 (877) 272-9616 Outside U.S.: 1 (201) 680-6578
Please see our “Events & Presentations” section of our website for a listing of upcoming earnings announcements and other key events.
You can contact CareDx’s Investor Relations via email by clicking here.
CareDx, Inc. was incorporated in the state of Delaware on December 21, 1998.
The IPO was underwritten and managed by Piper Jaffray & Co, Leerink Partners LLC, Raymond James and Mizuho Securities.
If your shares are held in street name (by your broker), you must notify the securities firm holding your stock. If you hold stock certificates in your name, address changes should be submitted in writing by U.S. Mail to our transfer agent: Computershare P.O. Box 30170 College Station, TX 77842
You can contact CareDx’s Media Relations via email by clicking here.